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ABSTRACT 
 
Aim: This paper is a report of a descriptive qualitative study of the evolution of women’s 
perceptions and experiences of ductal carcinoma in situ from the period near to diagnosis to 
one year later. 
 
Background: Ductal carcinoma in situ is a non-invasive breast condition where cancer cells 
are detected but confined to the ducts of the breast.  With treatment, the condition has a 
positive prognosis but ironically patients undergo treatment similar to that for invasive breast 
cancer.  There is a lack of longitudinal qualitative research studying women’s experiences of 
ductal carcinoma in situ, especially amongst newly diagnosed patients and how experiences 
change over time.  
 
Methods: Forty-five women took part in an initial interview following a diagnosis of ductal 
carcinoma in situ and twenty-seven took part in a follow-up interview 9-13 months later.  
Data were collected between January 2007 and October 2008.  Transcripts were analysed 
using a hybrid approach to thematic analysis. 
 
Findings: Women’s early perceptions of ductal carcinoma in situ merged and sometimes 
conflicted with their lay beliefs of breast cancer.  Perceptions and experiences of the 
condition shifted over time.  These overriding aspects were evident within four themes 
identified across the interviews: 1) perceptions of DCIS versus breast cancer, 2) from 
paradox to acceptance, 3) personal impact, and 4) support and interactions with others. 
 
Conclusion: This study represents one of the few longitudinal qualitative studies with newly 
diagnosed patients, capturing women’s initial and shifting experiences and perceptions of 
the condition.  The issues identified need to be recognised in clinical practice and supported 
appropriately. 
 
Keywords: ductal carcinoma in situ (DCIS); breast cancer; illness perceptions; breast care 
nurses; communication; information; support 
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SUMMARY STATEMENT 
 
What is already known about this topic 
• Ductal carcinoma in situ is a complex condition – patients are reassured it is non-
invasive and is not life-threatening, but they are often offered extensive treatment 
similar to that used to treat invasive breast cancer  
• Mixed results have been reported in the small amount of psychosocial research 
exploring women’s experiences, but this work has often been retrospective and 
conducted post-treatment  
• Little in-depth qualitative longitudinal research has been conducted in the period near 
to diagnosis  
 
What this paper adds 
• Women’s perceptions of ductal carcinoma in situ are diverse, merge and sometimes 
conflict with their lay beliefs of breast cancer, which can lead to difficult feelings and 
experiences  
• Women’s perceptions and experiences of ductal carcinoma in situ shift and develop 
over time during the diagnosis, treatment and post-treatment period as they interpret 
various cues encountered in their experience 
• Four key issues were identified relating to women’s perceptions of the condition, their 
feelings about treatment, the personal impact of the diagnosis and treatment, and 
interacting with others  
 
Implications for practice and/or policy 
• Clinicians should carefully consider the language they use to describe the ductal 
carcinoma in situ.  Further work should explore the potential for the development of 
clear, coherent and flexible communication guidelines for clinicians 
• There is a need for the provision of appropriate and tailored help, support and 
information in clinical practice to meet the specific and evolving needs of women 
diagnosed with ductal carcinoma in situ 
• Further research should continue to determine the most appropriate care, support 
and information for this group of patients 
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INTRODUCTION 
 
Since the introduction of routine breast screening, ductal carcinoma in situ (DCIS) has been 
increasingly detected in the UK and elsewhere (Houghton et al. 2003), and now represents 
around 20% of screen-detected breast cancers (National Health Service Breast Screening 
Programme (NHSBSP) 2008, NHSBSP 2006).  DCIS is a non-invasive condition where 
cancer cells are contained in the ducts of the breast (Leonard & Swain 2004), but uncertainty 
surrounds its natural history, particularly whether it would progress into invasive breast 
cancer (IBC) if untreated (Erbas et al. 2005).   
 
This has created two factions within the medical community (Graff, 2010).  Some view DCIS 
as a carcinoma in situ, emphasising that the majority of cases have a high risk of 
progression (Evans et al. 2001) and require detection and treatment to reduce the incidence 
of IBC (Cady, 1998).  However, because DCIS has not invaded into the surrounding breast 
tissue, others view DCIS as a pre-cancerous condition (Dell, 1997).  Some argue that the 
rise of DCIS detection constitutes an overdiagnosis (Baum, 1995) and that many cases 
would never develop into clinically life-threatening IBC during the patient’s lifetime (Mittra et 
al. 2000).   
 
With treatment most DCIS patients have an excellent prognosis (Ernster et al. 2000), but 
treatment is controversial because it is similar to that offered for IBC (including mastectomy, 
and possibly radiotherapy and hormone treatment).  Therefore, paradoxically patients are 
reassured that the condition is contained and not life-threatening, whilst recommended to 
undergo extensive, invasive treatment (Webb & Koch 1997).   
 
 
BACKGROUND 
 
Although research investigating the psychosocial impact of DCIS has emerged in Europe, 
Australia, Canada and the United States, it has received much less attention than IBC 
(Carrera & Payne 1999; Ganz, 2010).  Some studies suggest that DCIS patients recover and 
adjust relatively easily (Webb & Koch 1997, Nekhlyudov et al. 2006), possibly owing to the 
positive nature of the condition and reassurance received from health professionals.  
However, several quantitative studies in the US and Canada indicate that DCIS patients can 
experience similar levels of distress to IBC patients (Lauzier et al. 2009, Rakovitch et al. 
2003, Janz et al. 2005) and overestimate the risk of DCIS (Rakovitch et al. 2003, Partridge 
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et al. 2008a).  This suggests that DCIS patients may not appreciate their better prognosis 
(Morrow, 2004).  Qualitative work in Australia and the UK has emphasised that women can 
be confused about the treatment (De Morgan et al. 2002) and have specific information 
needs (Prinjha et al. 2006).   
 
Qualitative studies have also indicated that women previously diagnosed with DCIS hold 
diverse perceptions about the condition (ranging from it being breast cancer to it being a 
non-invasive condition or pre-cancer (De Morgan et al. 2002, Kennedy et al. 2008, Wong et 
al. 2008, Farmer 2000)), which are integrally linked to their experiences.  Inaccurate illness 
perceptions can negatively impact on patients’ experiences of any health condition (Buick, 
1997; Cameron & Moss-Morris, 2004).  The Common Sense Model of Illness 
Representations (CSM) (Leventhal, Meyer & Nerenz, 1980) suggests that illness perceptions 
develop from a variety of sources, including lay knowledge of the illness, the external 
environment and significant others (e.g. advice of clinicians), and current or previous 
experience with illness.  The CSM focuses on the patient, in how their implicit illness beliefs 
shape their coping and adjustment.  Ward (1993) highlights how this mirrors the focal point 
in nursing and recommends the CSM as a framework to guide knowledge development and 
nursing research.  Therefore, the CSM may provide a useful way for researchers and 
clinicians (including specialist nurses) to conceptualise patients’ perceptions of DCIS.  Two 
studies highlight how health professionals in the US and UK hold similarly diverse views of 
DCIS, and use different terminology when communicating about it with their patients 
(Partridge et al. 2008b, Kennedy, et al. 2009).  Illness perceptions therefore have important 
implications for patient’s experiences and provision of care, but further research is needed to 
explore perceptions of DCIS and identify the factors that inform their development from the 
point of diagnosis onwards. 
 
Much of the aforementioned research to date has been retrospective and conducted post-
treatment, thus obscuring women’s early experiences (Kennedy et al 2008).  Exceptionally, 
in a longitudinal quantitative study, Partridge et al. (2008a) recruited women within 3 months 
post-treatment.  However, in-depth qualitative research of women’s early perceptions and 
experiences of DCIS is rare.  An unpublished thesis (Carrera, 2001) is unique in qualitatively 
exploring 13 women’s experiences at 6 weeks and 6 months post-diagnosis, but did not 
explore whether perceptions changed over time.  Furthermore, most participants underwent 
conservative surgery, were treated by one surgeon, and the study was conducted in 1999, 
all of which limit the generalisibility of the findings.   
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The current study was conducted as part of a mixed methodology longitudinal project aiming 
to address these gaps in the literature by exploring the psychosocial impact of DCIS 
(Kennedy, 2009).  Fifty women with newly diagnosed DCIS completed a series of 
quantitative measures over the first year post-diagnosis (see Kennedy et al. 2010; Kennedy, 
2009) and were invited to participate in interviews near to diagnosis and again 9-13 months 
later, which are the focus of this paper.   
 
 
THE STUDY 
 
Aim 
This aim of this study was to describe the evolution of women’s perceptions and experiences 
of ductal carcinoma in situ from the period near to diagnosis to one year later. 
 
Design 
All participants in the overall longitudinal mixed methods project (Kennedy, 2009) were 
invited to complete interviews and/or questionnaires over the first year post-diagnosis.  The 
current paper focuses on the qualitative interviews, which have not been published 
elsewhere.  Given the paucity of previous research (Carrera & Payne 1999), a detailed 
qualitative insight was essential.  This embraces a phenomenological approach whereby 
each person’s unique view is considered meaningful and valid, and is particularly useful in 
under-researched areas (Streubert & Carpenter 1995).   
 
Participants 
Women recently diagnosed with DCIS (with no evidence of invasion, and not a recurrence) 
in 9 UK breast clinics were approached by their breast care nurse (BCN), who provided the 
study information sheet and, if they were interested in participating, passed their contact 
details to the researcher.  Nine months after diagnosis, all participants were invited to take 
part in a follow-up interview.  Although this meant that saturation was likely to be exceeded 
(Teddlie & Yu, 2007), this was considered more appropriate and ethical than purposefully 
choosing individuals to re-interview, or only interviewing until saturation.  Due to the study 
methods and lack of translating facilities, participants needed a fluent comprehension of 
English.   
 
Data collection 
Semi-structured interviews were conducted by the first author who had experience in this 
area.  Interviews were guided by a schedule developed from previous research (De Morgan 
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et al. 2002; Carrera 2001) (Figure 1) and were conducted at a time and place convenient for 
the participant (typically their home). 
 
Initial interviews were conducted between January 2007 and February 2008, on average 38 
days post-diagnosis.  In order not to overburden women, the interviews were designed to be 
brief, although the researcher encouraged women to talk as much or as little as they wished 
(range 10-84 minutes, average 33).  Follow-up interviews took place between October 2007 
and October 2008, at 9-13 months post-diagnosis, and lasted between 31 and 107 minutes 
(average 69).  
 
Ethical considerations 
All necessary NHS Ethics and Research and Development approvals were obtained.  All 
participants received an information sheet, gave written consent prior to each interview, and 
were reminded of their right to withdraw at any time.  Given the potential for distress, 
participants were reminded of the availability of their BCN and other sources of support.   
 
Data analysis 
Data was transcribed verbatim and analysed using thematic analysis (Braun & Clarke 2006).  
In recognition of the lead researcher’s prior experience of exploring women’s experiences of 
DCIS (Kennedy et al. 2008), a hybrid of inductive and deductive thematic analysis was 
undertaken (Fereday & Muir-Cochrane 2006).   
 
The initial interview data were comprehensively coded line-by-line using an inductive 
approach, aiming to provide a rich description, whilst also deductively referring and 
comparing to the findings in Kennedy et al. (2008).  Analysis of follow-up interviews focused 
on the changes in women’s experiences over time by incorporating with and comparing to 
the earlier interviews.  This comparative analysis was undertaken broadly by drawing on the 
whole sample, whilst also exploring several participants’ individual experiences (Smith, 
2003).  During this analysis any new aspects were noted.  Saturation in the follow-up 
analysis was reached after 18 interviews (Flick 2002), but the remaining 9 were reviewed for 
novel aspects.   
 
Rigour 
The first author carried out the analysis.  Two independent researchers coded several 
transcripts to verify the coding and the analysis was regularly discussed with the research 
team.  A reflective diary was kept throughout the project, which recorded any evolving ideas 
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during data collection and analysis.  Participants were sent a summary of the themes for 
member checking, to ensure that the findings ‘ring true’ (Ziebland & McPherson, 2006). 
 
 
FINDINGS 
 
Forty-five women participated in the initial interviews (25 were post-surgery and 20 pre-
surgery at this point in time).  They ranged between 34 and 84 years old (mean 58.8) and 
most were in a relationship (n=34).  Twenty-seven also participated in the follow-up 
interviews.  Compared to those who declined to be re-interviewed, follow-up interviewees 
were more likely to have been awaiting surgery at the time of the first interview and had 
reported higher illness coherence/understanding scores on the quantitative measures 
completed at 9 months (see Kennedy 2009).  Therefore, these women may have felt they 
had much to share at follow-up (e.g. experiences since surgery) and had a clear 
understanding of their diagnosis.   
 
At the time of follow-up, all women had completed their treatment (surgery and/or 
radiotherapy) and 5 had been diagnosed with multifocal DCIS or IBC during the surgery.  
These women were not excluded from the sample, but demonstrate the potential complexity 
of DCIS cases.  Treatment details and participant codes are presented in Table 1. 
 
The following sections explore four themes that emerged across the two interviews.  
Broadly, the initial interviews identified an overarching theme emphasising how women’s 
DCIS experiences merged and sometimes conflicted with their lay beliefs of IBC, and the 
follow-up interviews highlighted the shifting nature of women’s perceptions and experiences.   
 
 
Perceptions of DCIS versus breast cancer 
Participants’ main response to their diagnosis was a feeling of relief, especially given DCIS’ 
early, contained state and positive prognosis.  However, some equated it with their lay 
beliefs of breast cancer (often centred on having a lump and that a mastectomy indicated a 
more serious diagnosis).  This evoked feelings of fear, due to the term ‘carcinoma’ within 
DCIS and notions about treatment and prognosis.  This might reflect their lack of awareness 
of DCIS, prompting them to associate it with a condition about which they were more 
knowledgeable.   
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Paradoxically, many women had been asymptomatic but were advised to have a 
mastectomy, which led some to adjust their perception of breast cancer: 
 
when you get told that you have breast cancer all you can think of is what is my 
prognosis and am I going to live and will I lose my breast. It doesn’t dawn on you that 
actually there is a more detailed picture (p25) 
 
Initial perceptions of DCIS were informed by the terminology used by health professionals.  
Often these were ‘pre-cancer(ous)’ or ‘DCIS’, but other explanations included ‘early stages 
of breast cancer’, which contradicted with others being told ‘it wasn’t cancer’:  
 
the first word that was said to me was cancer, not DCIS, so as far as I’m concerned 
DCIS is cancer (p15) 
 
they say DCIS…it’s not cancer cause they haven’t labeled it as that (p23) 
 
Noticeably, several women were confused about whether DCIS was cancer or not: 
 
sometimes they refer to it as breast cancer and then when I went to oncology last 
week he said ‘it’s not breast cancer, it’s pre-cancer’, so it’s a little bit confusing as to 
whether it is or whether it isn’t (p41) 
 
This confusion was enhanced by conflicting information between what they were verbally 
told and the written information they were given, which was often primarily designed for 
women with IBC.   
 
During follow-up interviews, women’s perceptions of DCIS were still diverse, but for some 
these had clearly shifted over time as they had gathered more information about the 
condition.  Several women now expressed dissatisfaction and resentment with the term ‘pre-
cancer(ous)’:  
 
pre-cancer to my mind…lessens it and poo poo’s it…it is cancer and it should be 
treated as cancer (Follow-up interview (FU) p9) 
 
we’ve found out more from [internet/charities] because the consultant at the 
[hospital], all he would say was ‘no, no it’s not cancer…’ yet the information that you 
actually find out is that it is (FU p1) 
  
10
 
The treatment they had received earlier also influenced women’s current perceptions.  For 
some, the need for treatment in addition to surgery had indicated severity and “cancer”, 
whilst not requiring further treatment prompted a less serious and worrying view:  
 
if it was breast cancer I know I would have to go through treatment (FU p12) 
 
The consequences of the diagnosis and treatment also impacted on women’s perceptions.  
Some recovered fairly swiftly, had no long-term physical or emotional after effects and thus 
viewed it as relatively insignificant, whereas others described substantial changes to their 
lives, which they considered to be identical to those experienced by IBC patients: 
 
if you’re going to go through the treatment and the discrimination from the insurance 
companies and the time off work, and lose your career…then it almost begs to be 
recognised as cancer. (FU p25) 
 
Overall, women initially fluctuated between feelings of relief and uncertainty, where they 
were aware of the positive nature of the diagnosis, and fear of the risks they still faced.  
Confusion and conflict between these different perceptions created difficulty for some.  
Women’s perceptions were dynamic and evolved as they interpreted various cues and 
negotiated their way through the diagnosis, treatment and its consequences.   
 
 
From paradox to acceptance  
As in previous research (Kennedy et al. 2008) women appeared to fall somewhere on a 
continuum from treatment paradox to acceptance, and their position on this continuum was 
related to their perceptions of DCIS.  In each surgical group, some women reflected on the 
contradiction inherent in the invasive and extensive treatment advised (e.g. mastectomy, 
radiotherapy) for what was described, and they perceived, as a pre-cancer or non-cancerous 
condition.  Less extensive surgery seemed easier to accept, suggesting that WLE and 
lumpectomy are more in-keeping with beliefs about what is appropriate treatment for a non-
invasive condition:  
 
I was a bit surprised that he said and ‘we’ll do a mastectomy’ cause I thought well it’ll 
just be a tiny bit (p7) 
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Women dealt with any dissonant feelings about their diagnosis and treatment in a variety of 
ways: some emphasised the uncertainty and risk of DCIS, whereas others shifted their view 
of the condition to be more concordant with the necessity for treatment: 
 
[surgeon said] ‘I don’t know why you’re worried, you haven’t got cancer’. Ok well if I 
haven’t got cancer why am I having radiotherapy and why have you taken a 9cm by 
6cm by 3cm chunk out of my breast…? (p25) 
 
Views about treatment shifted over time.  Some women continued to emphasise the 
treatment paradox, but there was a greater sense of justifying the necessity of the treatment.  
However, as some women learned about the condition (and their perception of it shifted), 
their views about treatment also changed:  
 
as it was, it was DCIS and it’s only a little lump, and it’s only pre-.  And ‘oh a 
lumpectomy’s fine thank you, I don’t need anything more…’, but I may have felt 
differently had I known. (FU p23) 
 
Most still reflected on risk and uncertainty in order to justify the necessity of treatment, 
particularly those who were found to have IBC or multifocal DCIS.  Some women’s 
experiences had positively exceeded their expectations of the physical and emotional 
consequences of surgery, which helped them defend the treatment, whereas others reported 
unexpected side effects, disappointment with the aesthetic outcome, ambiguity about future 
treatment and recovery, and a degree of regret about undergoing surgery: 
 
if they could have categorically told me no it wasn’t going to spread I wouldn’t have 
had it…a little bit of me really regrets having it done…its taken my confidence (FU 
p42) 
 
In summary, women continued to justify the necessity of their treatment, but feelings about it 
were linked to their perceptions of DCIS and their experiences over time.   
 
 
Personal impact 
Some women felt they had not been greatly affected, and reported ‘sailing through’ the 
treatment.  However, others described physical difficulties (e.g. fatigue, discomfort), which 
some, particularly those who underwent more extensive surgery, were still enduring at the 
time of the follow-up interview. 
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At the initial interviews some women were not overly concerned since they had a positive 
view of DCIS.  Those awaiting a WLE (rather than a mastectomy) seemed less shocked and 
distressed.  However, others described how anxiety, disbelief and intrusive thoughts had 
impacted on their lives:  
 
I’m lying there in bed thinking I’m riddled with it…they must have gone through the 
milk ducts to get to the calcifications so has the cancer leaked out (p6) 
 
Women who were initially interviewed shortly after surgery reported mixed emotions 
including relief, anger, frustration, disbelief and guilt: 
 
at worst I feel mutilated and angry and upset…At best I feel relieved that it was 
nothing more (p39) 
 
I honestly feel really ashamed of myself for being so low about it all when really 
there’s no need…I’m really very, very lucky (p20) 
 
One of the most enduring emotions was the feeling of ongoing risk, which ranged from 
fleeting concerns to significant intrusive thoughts.  Persistent concerns were voiced about 
the possibility of recurrence or development of IBC, and some felt they were living in a cloud 
of vulnerability and uncertainty about the future.   
 
This concern continued in the follow-up interviews and led women to constantly seek 
reassurance.  At the time of the follow-up interviews, their first mammogram post-diagnosis 
(usually at 1 year) was imminent, which women saw as a major milestone and opportunity 
for reassurance that would enable them to move on. 
 
Some women described concern over the impact of the surgery on their appearance and 
body image and how this had left them feeling disappointed, vulnerable and self-conscious:  
 
I lacked the confidence when I went back [to work]…they were just looking at me and 
because I felt that I wasn’t perfect in that area…I felt very exposed (FU p6) 
 
These concerns were particularly evident in those who had undergone immediate 
reconstruction and were still in the midst of an ongoing reconstructive process.  For some, 
appearance concerns had impacted on their intimate relationships and confidence: 
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Even though I’ve had reconstruction surgery I don’t feel normal whatsoever, and I 
don’t know how I can go into a relationship, and that makes me angry (FU p42) 
 
Others felt positive or impartial about their appearance post-surgery; reflecting that they had 
little scarring or had already accepted their altered appearance.   
 
Overall, DCIS had a profound impact on some women, but this was juxtaposed with relief 
that their disease was caught early.   
 
 
Support and interactions with others  
Women's own lack of awareness and confusion about DCIS made telling others challenging.  
Some women used the terminology used by their clinicians, but several were concerned that 
this would lead others to perceive the diagnosis as serious and assume it was breast cancer.  
Some specifically tried to reduce their family’s concern by using the term ‘pre-cancer(ous)’ to 
minimise its significance: 
 
if I said I’ve got breast cancer she [mum] would have been hysterical, so I was very 
much ‘… a really, really, really tiny area of pre-cancerous cells’ (p24) 
 
In essence, women’s disclosure patterns fluctuated between a DCIS/less serious and breast 
cancer/more serious view.  In contrast, at the follow-up interviews, several emphasised not 
fully explaining DCIS and preferred instead to say it was early breast cancer in order to 
validate their treatment:  
 
I wanted them to know that there was a cancer in the title…you need to justify why 
you’re having such major surgery. (FU p24) 
 
Whilst most women felt they had received appropriate support from others, some reported 
how the diagnosis did not generate huge reactions:  
  
I feel as though everyone’s going ‘well that’s alright then’ and it’s not as though I want 
…loads of sympathy but a little bit of validation wouldn’t go amiss (p25) 
 
Just as women themselves held diverse perceptions of DCIS, their family, friends and health 
professionals’ views also varied which sometimes conflicted with the women’s own feelings: 
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[daughter] ‘oh well that’s great, it’s not cancer’…I couldn’t be truthful about how I was 
feeling. I shouldn’t be upset because it was pre-cancerous (p32) 
 
One year post-diagnosis, most participants felt they no longer needed health professionals’ 
support, but were grateful if it was still available.  BCNs were highlighted as providing 
invaluable support in most, but not all, cases: 
 
I was given a leaflet by [BCN]…then she whipped it out of my hand, she said ‘oh 
you’ve only got DCIS haven’t you, you can’t have the massage’ (FU p8) 
 
Thus, some women sensed an air of ‘only DCIS’ and a lack of support towards them.  They 
recognised that they were fortunate compared to IBC patients, but the diagnosis was still of 
major significance to them and they felt they had needed support.   
 
Most women tried to put the experience behind them and were happy that their family and 
friends did not dwell upon the episode.  However, some still needed support and received 
this from their peers who had undergone similar experiences, for example via the internet or 
buddy schemes.  However, some shied away from meeting women with IBC:  
 
I would feel like a fraud [attending a breast cancer group]…having not required 
chemotherapy or radiotherapy and having a very good prognosis (FU p24) 
 
There were mixed feelings about the value of DCIS-specific peer support.  Some felt it would 
have helped them to make sense of DCIS, but others were concerned about meeting women 
with different views of the condition or who had undergone different treatment since they 
thought this could cause concern rather than be beneficial.   
 
Overall, participants’ interactions with others highlight both the similarities and differences 
between DCIS and IBC.  Many tried to portray DCIS positively but some needed validation of 
their experience and ongoing support.   
 
 
DISCUSSION 
 
Given the potentially vulnerable time in women’s lives at which these interviews took place, a 
flexible and sensitive approach to recruitment and data collection was essential.  This 
  
15
entailed relying on BCNs to routinely identify and approach eligible patients, and also meant 
that the initial interview was conducted at a time best suited to each participant rather than at 
a specific, consistent number of days post-diagnosis.  The findings are also limited to the 
experiences of DCIS among a small number of White women treated in England, 27 of 
whom chose to participate in the follow-up interviews.  Therefore, we recognise the caveats 
of the sample and we do not claim that the findings are representative of all DCIS patients.  
 
Despite these limitations, the current findings make a valuable, novel contribution to the 
literature by identifying how women’s perceptions of DCIS, the treatment, and their 
emotions, can shift and evolve over time.  These findings have important implications for 
those providing care for DCIS patients, including specialist nurses.  
 
Previous retrospective research has indicated that perceptions of DCIS vary amongst 
patients (De Morgan et al. 2002, Kennedy et al. 2008), but the current study has shown this 
diversity is present from diagnosis onwards and that perceptions can shift over time.  The 
findings endorse the Common Sense Model of Illness Representations (CSM) (Leventhal et 
al. 1980) in emphasising how illness perceptions are dynamic (Leventhal et al. 1998) and 
develop from various sources, including previous illness experience, terminology used by 
clinicians, treatment received (e.g. ‘if I need a mastectomy, then it is cancer’) and 
consequences of the experience.  As highlighted by Ward (1993), the CSM embraces the 
need for health professionals to recognise patients’ perceptions of their illness.  It has 
particular relevance for advanced nursing practice to help nurses understand patients’ 
perspectives in order to provide patient-focused individualised support and care.  
 
The key issue of whether or not DCIS is considered cancer resonated throughout 
participants’ accounts and concords with previous research (De Morgan et al. 2002, 
Napoles-Springer et al. 2007).  Women fluctuated between viewing themselves as having 
cancer and having a non-cancerous condition, and these conflicting views were a cause of 
distress for some.  Other research has suggested that women newly diagnosed with screen-
detected breast cancer can hold a positive conceptual model of their disease (i.e. it is caught 
early and treatable), yet at times the same women resorted to a traditional view involving 
fear and risk (Farmer, 2000).  Farmer explained the struggle between these views as due to 
the cognitive conflict when ‘early’ ‘minor cancer’ requires major treatment.  The current study 
found views of DCIS that were akin to those identified by Farmer and that these views were 
influenced by the treatment advised/received.  Specialist BCNs therefore need to elicit 
patients’ views of their diagnosis and treatment in order to provide support and information to 
help reconcile any perceived conflict.  
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The way in which health professionals describe DCIS strongly influenced women’s early 
perceptions of their diagnosis.  As noted previously in research with patients (Kennedy et al. 
2008) and clinicians (Partridge et al. 2008b, Kennedy et al. 2009), a variety of terms were 
used.  Fallowfield (1997) argues that avoiding the word cancer or using euphemisms can 
cause distress and prevent successful adjustment.  This is interesting in the context of DCIS 
where the situation is compounded by medical ambiguity about whether it meets the criterion 
for cancer (Graff, 2010).   
 
Overall, the term ‘pre-cancer(ous)’ seemed counterproductive in helping some women 
understand and adjust to the diagnosis and treatment.  This supports previous critics of this 
term (Kelly 2002) and a NHSBSP report highlighting the difficulties of terminology in DCIS 
(Goldsmith et al. 2007).  Whilst Goldsmith et al. refer to written information, the current study 
indicates that verbal communication also requires consideration.  From a patient-centred 
perspective, the language used across sources (e.g. clinicians, leaflets) should be non-
ambiguous, coherent and understandable (Godby 2000, Prinjha et al. 2006).  However, this 
is challenging given the variability of labels currently being used and the individual 
differences between patients, such that outright consistency of terminology may not be 
beneficial to individual patient needs.  Clearly clinicians should carefully consider their 
communication methods, but further research is needed in this area.  De Morgan et al. 
(2011) recently developed a communication aid to help clinicians in Australia explain DCIS 
to their patients.  A small evaluation of this tool with clinicians and patients 12-18 months 
post-diagnosis suggests this may be a valuable resource but research is needed to explore 
its use in other health care systems and with newly diagnosed patients.  
 
A lack of awareness about DCIS led women to struggle to understand the condition and 
explain it to others, whilst at the same time wanting to protect their loved ones.  Some 
women minimised the diagnosis by using a less serious label (‘pre-cancer’) when telling 
others.  Similar findings have been reported in research with other ambiguous conditions, 
including men’s experiences of undergoing active surveillance for low-risk prostate cancer 
(Oliffe et al. 2009), whereby some men viewed the cancer as benign and downplayed the 
condition in order to live a normal life, but this stance reduced their ability to talk to others 
about their concerns.  This could explain why some women changed their approach towards 
discussing DCIS, subsequently using the term ‘cancer’ in order to validate their experience 
and enable open discussions with others.   
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Previous authors (Farmer 2000, Partridge et al. 2008a) have speculated that DCIS patients 
may receive less time, information and support from others because the condition is viewed 
positively.  This was evident in some women’s accounts that their DCIS was trivialised (see 
also Kennedy et al. 2008).  Overall, how the diagnosis of any condition is communicated is 
crucial in determining how patients and others perceive the condition and, in turn, potentially 
the support they receive and provide to others (Buick & Petrie, 2002; Buick, 1997). 
   
The good prognosis associated with DCIS clearly contributed to the relief and adjustment 
evident amongst some women, supporting previous research (Webb & Koch 1997, Farmer, 
2000).  However, other women endured emotional and physical difficulties, including anxiety 
and appearance concerns, which mirror the quantitative work conducted alongside the 
current study (Kennedy et al. 2010) and the experience of IBC patients (Schmid-Buchi et al. 
2008).  Other concerns appear unique to DCIS, particularly how the complexities and 
uncertainty of the condition are perceived and understood (De Morgan et al. 2002, Kennedy 
et al. 2008).  It is important that specialist BCNs, working with other members of their 
multidisciplinary teams, identify patients experiencing high levels of distress or 
misunderstandings about DCIS in order that appropriate support and care can be provided. 
 
 
CONCLUSION   
 
This study provides an important insight into women’s initial perceptions and individual 
experiences of DCIS and how these evolve over time.  Specialist BCNs have a key role in 
ensuring DCIS patients’ support needs are met, including the provision of appropriate, up-to-
date, tailored information to meet their needs throughout their journey.  In order to achieve 
this further research is needed to determine appropriate and effective means of providing 
patient care, support and information.  The CSM offers a relevant theoretical framework to 
guide both research and provision of care in this area.    
 
REFERENCES 
Baum M. (1995). Screening for breast cancer, time to thank and stop?  Lancet, 346(8972), 
436-7. 
 Braun V. & Clarke V. (2006). Using thematic analysis in psychology. Qualitative Research in 
Psychology, 3 , 77-101.  
  
18
Buick D. L. (1997). Illness representations and breast cancer: Coping with radiation and 
chemotherapy. In: Petrie K.J. & Weinman J.A. (eds.). Perceptions of health and illness: 
Current research and applications. Harwood Academic Publishers: Amsterdam, 
Netherlands, pp.379-409.  
Buick D.L., & Petrie K.J. (2002). "I know just how you feel": The validity of healthy women's 
perceptions of breast cancer patients receiving treatment.  Journal of Applied Social 
Psychology, 32(1), 110-123. 
Cady B (1998).  How to prevent invasive breast cancer: Detect and excise duct carcinoma in 
situ.  Journal of Surgical Oncology, 69(2), 60-62. 
Cameron L.D., & Moss-Morris R. (2004). Illness-related cognition and behaviour.  In A. 
Kaptein, & J. Weinman (Eds.), Health psychology (pp.84-110).  Blackwell Publishing: 
Malden, US. 
Carrera C. (2001). Ductal carcinoma in situ (DCIS) of the breast: Psychological issues 
surrounding its detection, diagnosis and treatment. Unpublished doctoral thesis: 
University of Southampton, Southampton.  
Carrera C. & Payne S. (1999). Ductal carcinoma in situ (DCIS) of the breast: The need for 
psychosocial research. Psycho-Oncology, 8 (6), 538-545.  
De Morgan S., Butow P.N., Lobb E.A., Price M.A. & Nehill C. (In press). Development and 
pilot testing of a communication aid to assist clinicians to communicate with women 
diagnosed with ductal carcinoma in situ.  Supportive Care in Cancer, DOI: 
10.1007/s00520-010-1040-5.   
De Morgan S., Redman S., White K. J., Cakir B. & Boyages J. (2002). "Well, have I got 
cancer or haven't I?" the psycho-social issues for women diagnosed with ductal 
carcinoma in situ. Health Expectations, 5 (4), 310-318.  
Dell D.D (1997).  Common questions about ductal carcinoma in situ.  American Journal of 
Nursing, 97(5), 61.  
Erbas B., Provenzano E., Armes J. & Gertig D. (2005). The natural history of ductal 
carcinoma in situ of the breast: A review. Breast Cancer Research & Treatment, 97 (2), 
135-144.  
Ernster V. L., Barclay J., Kerlikowske K., Wilkie H. & Ballard-Barbash R. (2000). Mortality 
among women with ductal carcinoma in situ of the breast in the population-based 
surveillance, epidemiology and end results program. Archives of Internal Medicine, 160 
(7), 953-958.  
Evans A.J., Pinder S.E., Ellis I.O. & Wilson A.R. (2001).  Screen detected ductal carcinoma 
in situ (DCIS): Overdiagnosis or an obligate precursor of invasive disease?  Journal of 
Medical Screening, 8(3), 149-151. 
  
19
Fallowfield L.J. (1997). Truth sometimes hurts but deceit hurts more. Annals of the New York 
Academy of Sciences, 809 , 525-536. 
Farmer A. J. (2000). The minimization to clients of screen-detected breast cancer: A 
qualitative analysis. Journal of Advanced Nursing, 31 (2), 306-313.  
Fereday J. & Muir-Cochrane E. (2006). Demonstrating rigor using thematic analysis: A 
hybrid approach of inductive and deductive coding and theme development. International 
Journal of Qualitative Methods [online], 5 (1), Retrieved 15 May 2008 from 
http://www.ualberta.ca/~iiqm/backissues/5_1/pdf/fereday.pdf  
Flick U. (2002). An introduction to qualitative research.  Sage Publications: London.  
Ganz P (2010). Quality of life issues in patients with ductal carcinoma in situ.  Journal of the 
National Cancer Institute Monographs, 41, 218-222.  
Godby C. J. (2000). Women's attitudes to false positive mammography results. A formerly 
clueless patient responds. British Medical Journal, 321 (7273), 1409-10.  
Goldsmith M., Bankhead C. & Austoker J. (2007). Improving the quality of the written 
information sent to women about breast screening: Evidence-based criteria for the 
content of letters and leaflets. No. 64, NHS Cancer Screening Programmes: Sheffield.  
Graff S (2010). Ductal carcinoma in situ: Should the name be changed?  Journal of the 
National Cancer Institute, 102(1), 6-8. 
Houghton J., George W.D., Cuzick J., Duggan C., Fentiman I.S., Spittle M., et al. (2003).  
Radiotherapy and tamoxifen in women with completed excised ductal carcinoma in situ of 
the breast in the UK, Australia and New Zealand: Randomised controlled trial.  Lancet, 
362 (9378), 95-102. 
Janz N.K., Mujahid M., Lantz P.M., Fagerlin A., Salem B., Morrow M., Deapen D. & Katz S.J. 
(2005). Population-based study of the relationship of treatment and sociodemographics 
on quality of life for early stage breast cancer. Quality of Life Research, 14 (6), 1467-
1479.  
Kelly P. T. (2002). Explaining ductal carcinoma in situ to patients: The role of specific 
information and absolute risks. In: Silverstein M.J. (ed.). Ductal carcinoma in situ of the 
breast. 2nd ed. Lippincott Williams & Wilkins: Baltimore, pp. 572-575.  
Kennedy F. (2009). The psychosocial impact and perception of ductal carcinoma in situ 
(DCIS). Unpublished doctoral thesis, University of the West of England: Bristol.  
Kennedy F., Harcourt D., Rumsey N. & White P. (2010). The psychosocial impact of ductal 
carcinoma in situ (DCIS): A longitudinal prospective study. The Breast, 19, 382-387.  
Kennedy F., Harcourt D. & Rumsey N. (2008). The challenge of being diagnosed and treated 
for ductal carcinoma in situ (DCIS). European Journal of Oncology Nursing, 12 (2), 103-
111.  
  
20
Kennedy F., Harcourt D. & Rumsey N. (2009). Perceptions of ductal carcinoma in situ 
(DCIS) among UK health professionals. The Breast, 18 (2), 89-93.  
Lauzier S., Maunsell E., Levesque P., Mondor M., Robert J., Robidoux A. & Provencher L. 
(2009). Psychological distress and physical health in the year after diagnosis of DCIS or 
invasive breast cancer. Breast Cancer Research & Treatment, 120: 685-691.  
Leonard G.D. & Swain S.M. (2004). Ductal carcinoma in situ, complexities and challenges. 
Journal of the National Cancer Institute, 96 (12), 906-920.  
Leventhal H., Leventhal E. & Contrada R.J. (1998). Self-regulation, health, and behavior: A 
perceptual-cognitive approach. Psychology & Health, 13 , 717-733.  
Leventhal H., Meyer D. &  Nerenz D. (1980). The common sense representation of illness 
danger. In: Rachman S. (ed.). Medical psychology. Vol 2, Pergamon: New York, pp. 7-30. 
Mittra I., Baum M., Thornton H. & Houghton J. (2000).  Is clinical breast examination an 
acceptable alternative to mammographic screening?  British Medical Journal, 321(7268), 
1071-1073. 
Morrow M. (2004). The certainties and the uncertainties of ductal carcinoma in situ.  Journal 
of the National Cancer Institute, 96(6), 424-425. 
Napoles-Springer A.M., Livaudais J.C., Bloom J., Hwang S. & Kaplan C.P. (2007). 
Information exchange and decision making in the treatment of Latina and White women 
with ductal carcinoma in situ. Journal of Psychosocial Oncology, 25 (4), 19-36. 
Nekhlyudov L., Kroenke C.H., Jung I., Holmes M.D. & Colditz G.A. (2006). Prospective 
changes in quality of life after ductal carcinoma-in-situ: Results from the nurses' health 
study. Journal of Clinical Oncology, 24 (18), 2822-2827.  
NHSBSP (2008). NHS Breast Screening Programme Annual Review 2008. NHS Cancer 
Screening Programmes: Sheffield.  
NHSBSP (2006). Screening for breast cancer in England: Past and future. No. 61, NHS 
Cancer Screening Programmes: Sheffield.  
Oliffe J.L., Davison B.J., Pickles T. & Mroz L. (2009). The self-management of uncertainty 
among men undertaking active surveillance for low-risk prostate cancer. Qualitative 
Health Research, 19 (4), 432-443.  
Partridge A., Adloff K., Blood E., Dees E.C., Kaelin C., Golshan M., Ligibel J., de Moor J.S., 
Weeks J., Emmons K. & Winer E. (2008a). Risk perceptions and psychosocial outcomes 
of women with ductal carcinoma in situ: Longitudinal results from a cohort study. Journal 
of the National Cancer Institute, 100 (4), 243-251.  
Partridge A., Winer J.P., Golshan M., Bellon J.R., Blood E., Dees E.C., Sampson E., 
Emmons K.M. & Winer E. (2008b). Perceptions and management approaches of 
physicians who care for women with ductal carcinoma in situ. Clinical Breast Cancer, 8 
(3), 275-280.  
  
21
Prinjha S., Evans J. & McPherson A. (2006). Women's information needs about ductal 
carcinoma in situ before mammographic screening and after diagnosis: A qualitative 
study. Journal of Medical Screening, 13 (3), 110-114.  
Rakovitch E., Franssen E., Kim J., Ackerman I., Pignol J.P., Paszat L., Pritchard K.I., Ho C. 
& Redelmeier D.A. (2003). A comparison of risk perception and psychological morbidity in 
women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer 
Research & Treatment, 77 (3), 285-293.  
Schmid-Buchi S., Halfens R.J., Dassen T. & van den Borne B. (2008). A review of 
psychosocial needs of breast-cancer patients and their relatives. Journal of Clinical 
Nursing, 17 (21), 2895-2909.  
Smith N. (2003).  Cross-sectional profiling and longitudinal analysis: research notes on 
analysis in the longitudinal qualitative study, 'Negotiating Transitions to Citizenship'.  
International Journal of Social Research Methodology, 6(3), 273-277. 
Streubert H.J. & Carpenter D.R. (1995). Qualitative research in nursing advancing the 
humanistic imperative.  J.B. Lippincott & Company: Pennsylvania.  
Teddlie C & Yu F. (2007).  Mixed methods sampling: A typology with examples.  Journal of 
Mixed Methods Research, 1 (1), 77-100. 
Ward S.E. (1993).  The common sense model: an organizing framework for knowledge 
development in nursing.  Scholarly Inquiry for Nursing Practice: An International Journal, 
7(2), 79-90. 
Webb C. & Koch T. (1997). Women's experiences of non-invasive breast cancer: Literature 
review and study report. Journal of Advanced Nursing, 25 (3), 514-525. 
Wong S.T., Chen W., Bottorff J.L. & Hislop T.G. (2008). Treatment decision making among 
Chinese women with DCIS. Journal of Psychosocial Oncology, 26 (4), 53-73.   
Ziebland S., & McPherson A. (2006).  Making sense of qualitative data analysis: An 
introduction with illustrations from DIPEx (personal experiences of health and illness).  
Medical Education, 40(5), 405-414.  
 
Figure 1: Semi-structured interview questions  
 
Initial interview 
- Can you start by describing the time leading up to your diagnosis? 
- In your own words, how do you understand your diagnosis? 
- How did the doctor/nurse describe the condition?  Any other terms? 
- Had your previously heard of [use term individual used earlier) before? 
- Has your doctor spoke to you about treatments yet?   
- How do you feel about the diagnosis and treatment? 
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- Anything else you’d like to mention? 
 
Follow-up interview  
- Can you tell me what’s happened since we last met? 
- How did you feel after the treatment(s)?  Have your feelings changed over the last 
year? 
- Has the diagnosis/treatment changed the way you feel about your body/ 
appearance? 
- How do you view/feel about your diagnosis of DCIS now? 
- How do you feel about the information you have received about DCIS? 
- How do you feel about the support you’ve received during the past year? 
- Are there any recommendations you would make for future care/support for DCIS 
patients? 
 
 
Table 1 – Diagnosis and treatment details (Note: shaded rows indicate participants who took 
part in the initial interview only) 
Participant Timing of initial 
interview 
Detection Surgery 
Received 
Radiotherapy Hormone 
therapy 
Any other 
details 
1 Pre-op Mammogram WLE+RX *   
2 Pre-op Mammogram WLE    
3 Pre-op Mammogram M+R    
4 Pre-op Symptomatic M+R * *  
5 Pre-op Mammogram WLE * * IBC at 
surgery 
6 Pre-op Mammogram M+R    
7 Pre-op Mammogram M    
8 Pre-op Mammogram WLE / M+R   Multi-focal 
DCIS  
9 Pre-op Mammogram WLE / M+R   IBC at 
surgery 
10 Pre-op Mammogram WLE * *  
11 Pre-op Mammogram BM+R    
12 Pre-op Mammogram WLE    
13 Pre-op Symptomatic M    
14 Pre-op Symptomatic M+R    
15 Pre-op Mammogram WLE    
16 Pre-op Mammogram WLE *   
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17 Pre-op Mammogram M  *  
18 Post 1st op, pre-
op 2nd op 
Mammogram WLE+RX / M *  Multi-focal 
DCIS 
19 Post 1st op, pre 
re-excision 
Mammogram WLE+RX  *  
20 Post 1st op, pre 
re-excision 
Mammogram WLE+RX    
21 Post-op Symptomatic WLE+RX / M  *  
22 Post-op Mammogram WLE+RX    
23 Post-op Symptomatic WLE * * IBC at 
surgery 
24 Post-op Symptomatic M+R    
25 Post-op Mammogram WLE *   
26 Post-op Symptomatic M  *  
27 Post-op Mammogram WLE    
28 Post-op Symptomatic WLE    
29 Post-op Mammogram WLE    
30 Post-op Mammogram WLE / M  *  
31 Post-op Mammogram WLE *   
32 Post-op Mammogram WLE    
33 Post-op Mammogram WLE * *  
34 Post-op Mammogram WLE    
35 Post-op Mammogram WLE  *  
36 Post-op Mammogram WLE  *  
37 Post-op Mammogram WLE *   
38 Post-op Symptomatic M    
39 Post-op Mammogram M    
40 Post-op Mammogram WLE *   
41 Post-op Mammogram WLE+RX *   
42 Post-op Symptomatic Lumpectomy 
/ M+R 
   
43 Post-op Symptomatic M * *  
44 Post-op Mammogram WLE *   
45 Post-op Mammogram WLE / M    
 
Key: M = mastectomy; +R = plus reconstruction; BM = bilateral mastectomy; WLE = wide local excision; +RX = re-excision 
* indicates received treatment 
 
